It has been stated that the Covid-19 vaccine developed by Pfizer/BioNTech will require approval from the US Food and Drug Administration (FDA) for use in children aged 11 and under until autumn.
The company’s Head of Clinical Vaccine Research and Development, Dr. Alejandra Gurtman spoke at a virtual symposium held by Johns Hopkins University and the University of Washington to discuss details on pediatric vaccine trials.
Gurtman added that the company will apply to the FDA for the use of the vaccine in children aged 5 to 11 by September or October, adding that it will also apply for approval for children younger than 5 years old.
Stating that vaccine trials on children started with the participation of 4,500 volunteer children in March, Gurtman stated that different doses of vaccine were given to children in different age groups in the study.
Gurtman explained in the study that 3 micrograms were given to children aged 6 months to 5 years, 10 micrograms to children 5 to 11 years of age, and 30 micrograms to children over 12 years of age.
4 COUNTRIES, 90 CENTERS
Stating that the studies are currently being conducted in 90 centers in the USA, Finland, Poland and Spain, Gurtman stated that about two-thirds of the participating children received two doses of the vaccine 21 days apart, and one-third were given a placebo.
The FDA approved the use of the Pfizer/BioNTech vaccine for Americans aged 16 years and older in December 2020, and for Americans aged 12 years or older last May.
On the other hand, like Pfizer/BioNTech, Moderna and AstraZeneca are testing the efficacy and safety of Covid-19 vaccines on children.
In mid-March, Moderna announced that it was testing the Covid-19 vaccine in children aged 6 months to 12 years, but did not expect results until early 2022.
The Covid-19 vaccine, developed by AstraZeneca and Oxford University in the United Kingdom, is being tested in children aged 6 to 17.
3 OUT OF 10 PARENTS SAY “I’M SANCTIONED”
In a recent survey by the Kaiser Family Foundation, parents were asked whether they would vaccinate their children when a Covid-19 vaccine is approved and available for their child’s age group. Only 3 out of 10 parents (29 percent) stated that they would “immediately” vaccinate their children under the age of 18.
The survey also said that 15 percent of parents plan to vaccinate their children only if necessary for school, and 19 percent said they would “absolutely” not vaccinate their children.
The American Academy of Pediatrics stated that more than 4 million children in the USA were caught in Covid-19, while children accounted for only 0.1 percent of the total loss of life in the USA.